Liquidia (LQDA) Income from Non-Controlling Interests (2021 - 2024)
Liquidia (LQDA) posted quarterly Income from Non-Controlling Interests of $2000.0 for Q3 2024, down 33.33% year-over-year from $3000.0 in Q4 2023, and little changed quarter-over-quarter from $2000.0 in Q2 2024.
Liquidia (LQDA) Income from Non-Controlling Interests (2021 - 2024) Analysis & Trends
Liquidia's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $2000.0 for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | -32,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 14,000.00 |